Molecular Mechanism by Which Chidamide Reverses Osimertinib Resistance in Lung Adenocarcinoma by Downregulating ARSD

Epidaza (chidamide) - Chipscreen

Tagrisso (osimertinib) - AstraZeneca

X. Huang; X. Xu; Y. Chen; Y. Guo; J. Chen; J. Chen; G. Cao; G. Chen; Y. Wang; Z. Zhang; W. Su

Jul 31, 2026